Seminar movie: Professor Dan Peer speaks about harnessing RNAi-based nanomedicines for precision medicine.

Special emphasis is placed on delivery strategies that target subsets of leukocytes such as the integrin-targeted and stabilized nanoparticle platforms and gagomers, and examples from inflammatory bowel diseases, viral infection and blood cancers are discussed. Personalized nanomedicine has the power to combine nanomedicine with clinical and molecular biomarkers ("OMICS" data) achieving improved prognosis and disease management as well as individualized drug selection and dosage profiling to ensure maximum efficacy and safety. In this presentation, aspects of personalized nanomedicine both from the drug and the carrier standpoint will be detailed.

This is the first in a series of seminars on presented by leading researchers on key topics in nanotechnology. The series celebrates the 50th anniversary of the Feynman Lectures on Physics. For more seminars in this series keep an eye on our multimedia channel.

Further reading

RNAi nanomedicines: challenges and opportunities within the immune system Weinstein S and Peer D 2010 Nanotechnology 21 232001
Exploring arrays of vertical one-dimensional nanostructures for cellular investigations Bonde S et al 2014 Nanotechnology 25 362001
Has nanomedicine lived up to its promise? Venkatraman S 2014 Nanotechnology 25 372501